Paper - WANFANG MED ONLINE

You Position: Home > Paper

Local treatment of osteoporosis with alendronate-loaded calcium phosphate cement

( views:65, downloads:4 )

Author:: No author available

Journal Title:: Chinese Medical Journal

Issue:: 22

DOI:: 10.3760/cma.j.issn.0366-6999.20141670

Key Word:: local treatment of osteoporosis;alendronate-loaded calcium phosphate cement;trabecular bone microarchitecture;biomechanical properties;micro-CT drug delivery system

Abstract： Background A new treatment strategy is to target specific areas of the skeletal system that are prone to clinically significant osteoporotic fractures.We term this strategy as the "local treatment of osteoporosis".The study was performed to investigate the effect of alendronate-loaded calcium phosphate cement (CPC) as a novel drug delivery system for local treatment of osteoorosis.Methods An in vitro study was performed using CPC fabricated with different concentrations of alendronate (ALE,0,2,5,10 weight percent (wt％)).The microstructure,setting time,infrared spectrum,biomechanics,drug release,and biocompatibility of the composite were measured in order to detect changes when mixing CPC with ALE.An in vivo study was also performed using 30 Sprague-Dawley rats randomly divided into six groups:normal,Sham (ovariectomized (OVX) + Sham),CPC with 2％ ALE,5％ALE,and 10％ ALE groups.At 4 months after the implantation of the composite,animals were sacrificed and the caudal vertebrae (levels 4-7) were harvested for micro-CT examination and biomechanical testing.Results The setting time and strength of CPC was significantly faster and greater than the other groups.The ALE release was sustained over 21 days,and the composite showed good biocompatibility.In micro-CT analysis,compared with the Sham group,there was a significant increase with regard to volumetric bone mineral density (BMD) and trabecular number (Tb.N) in the treated groups (P ＜0.05).Trabecular spacing (Tb.Sp) showed a significant increase in the Sham group compared to other groups (P ＜0.01).However,trabecular thickness (Tb.Th) showed no significant difference among the groups.In biomechanical testing,the maximum compression strength and stiffness of trabecular bone in the Sham group were lower than those in the experimental groups.Conclusions The ALE-loaded CPC displayed satisfactory properties in vitro,which can reverse the OVX rat vertebral trabecular bone microarchitecture and biomechanical properties in vivo.

Reference

[1]李宁华,区品中,朱汉民,等.中国中老年人群骨折患病率调查[J].2003,(8).
[2]苗军,刘春蓉,王继芳,等.复合抗生素对磷酸钙骨水泥理化性质影响作用的研究[J].2004,(3).
[3]T M, Keaveny,W C, Hayes.A 20-year perspective on the mechanical properties of trabecular bone.[J].1993,115(4B).
[4]Jindong Z,Hai T,Qiang WB,etc.Evaluation of a novel osteoporotic drug delivery system in vitro: alendronate-loaded calcium phosphate cement.[J].2010,33(8).
[5]Fini M,Bigi A,Torricelli P,etc.Alendronate and Pamidronate calcium phosphate bone cements: Setting properties and in vitro response of osteoblast and osteoclast cells[J].2009,103(1).
[6]Nedeljkovic J,Kuljanin J,Marinkovic V V.Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions.[J].2002,28(6).
[7]Dennis M Black,Steven R Cummings,David B Karpf,etc.Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures[J].1996,348(9041).
[8]Sharpe M,dis.co.nz,Noble S,etc.Alendronate: an update of its use in osteoporosis.[J].2001,61(7).
[9]Sune Larsson,Thomas Bauer.Use of Injectable Calcium Phosphate Cement for Fracture Fixation&colon; A Review[J].2002,395(&NA;).
[10]Declercq H,Pieters IY,Van den Vreken NM.Characterization of calcium phosphate cements modified by addition of amorphous calcium phosphate.[J].2010,6(2).
[11]Si-Hoe KM,Teo JCM,Teoh SH,etc.Correlation of cancellous bone microarchitectural parameters from microCT to CT number and bone mechanical properties[J].2007,27(2).
[12]Libicher M,Nawroth P,Hillmeier J,etc.Osseous integration of calcium phosphate in osteoporotic vertebral fractures after kyphoplasty: initial results from a clinical and experimental pilot study.[J].2006,17(8).
[13]Y.Huang,H.F.Shao,C.S.Liu.Study on the Applied Properties of Tobramycin-Loaded Calcium phosphate Cement[J].2001,0(192).
[14]Park YS,Park JH,Rhim SY.Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.[J].2009,31(5).
[15]M, Bohner,J, Lema?tre,H P, Merkle,etc.Control of gentamicin release from a calcium phosphate cement by admixed poly(acrylic acid).[J].2000,89(10).
[16]Yun MH,Kwon KI.High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans.[J].2006,40(1).
[17]Makoto Otsuka,Yoshinori Nakahigashi,Yoshihisa Matsuda,etc.A novel skeletal drug delivery system using self-setting calcium phosphate cement VIII: the relationship between in vitro and in vivo drug release from indomethacin-containing cement[J].1997,43(2-3).
[18]Degroot K.,Kurashina K.,Hirano M.,etc.In Vivo Study of Calcium Phosphate Cements - Implantation of an Alpha-Tricalcium Phosphate Dicalcium Phosphate Dibasic Tetracalcium Phosphate Monoxide Cement Paste[J].1997,18(7).
[19]Roux S.New treatment targets in osteoporosis.[J].2010,77(3).
[20]Xiupeng Wang,Hong Xiang,Ling Chen.Influence of Anti-Washout Agents on the Rheological Properties and Injectability of a Calcium Phosphate Cement[J].2007,81B(2).
[21]Kenneth E SPoole,Juliet ECompston.Osteoporosis and its management[J].2006,333(7581).
[22]Civitelli R,Strampel W,Emkey R.Safety considerations with bisphosphonates for the treatment of osteoporosis.[J].2007,30(9).
[23]Babak Chehroudi,Karen A. Long,Donald M. Brunette,etc.Controlled Release of Alendronate from Polymeric Films[J].2009,20(5).
[24]Reid IR,Hu H,Hue TF,etc.Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.[J].2007,356(18).
[25]Takechi M,Suzuki K,Miyamoto Y,etc.Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement.[J].1998,39(2).
[26]Ooms EM.,van de Heuvel MT.,Jeschke B.,etc.Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone[J].2003,24(6).
[27]Jin Y,Ma YL,Zhang YH,etc.Quantitative associations between osteocyte density and biomechanics, microcrack and microstructure in OVX rats vertebral trabeculae.[J].2008,41(6).
[28]Devogelaer JP,Tucci JR,Liberman UA,etc.Ten years' experience with alendronate for osteoporosis in postmenopausal women.[J].2004,350(12).
[29]Michael P.Hofmann,Anne M.Young,Uwe Gbureck.FTIR-monitoring of a fast setting brushite bone cement: effect of intermediate phases[J].2006,16(31).
[30]Resnick NM,Bhattacharya R,Beck TJ,etc.Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial.[J].2005,20(9).
[31]Pieters IY.,Demaeyer EAP.,Verbeeck RMH..Stoichiometry of K+- and Co32--Containing Apatites Prepared by the Hydrolysis of Octacalcium Phosphate[J].1996,35(20).
[32]Ito A,Tokudome Y,Otsuka K,etc.Efficacy of the injectable calcium phosphate ceramics suspensions containing magnesium, zinc and fluoride on the bone mineral deficiency in ovariectomized rats.[J].2008,97(1).
[33]Yingjun Wang,Chang Du,Wei Huang,etc.A novel PHBV/HA microsphere releasing system loaded with alendronate[J].2009,29(7).
[34]S, Zhou,X, Deng,X, Li.Investigation on a novel core-coated microspheres protein delivery system.[J].2001,75(1-2).
[35]Lo WJ,Grant DM.Hydroxyapatite thin films deposited onto uncoated and (Ti, Al, V)N-coated Ti alloys.[J].1999,46(3).
[36]Yang Q,Tseng WJ,Liu DM,etc.Structural evolution of sol-gel-derived hydroxyapatite.[J].2002,23(7).
[37]Apelt D,Theiss F,El Warrak AO,etc.In vivo behavior of three different injectable hydraulic calcium phosphate cements.[J].2004,25(7).
[38]McCalden RW,McGeough JA,Court Brown CM.Age-related changes in the compressive strength of cancellous bone. The relative importance of changes in density and trabecular architecture.[J].1997,79(3).
[39]Bohner M,Gbureck U,Barralet JE.Technological issues for the development of more efficient calcium phosphate bone cements: A critical assessment[J].2005,26(33).
[40]Siris ES,Harris ST,Eastell R,etc.Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study.[J].2005,20(9).
[41]Janvier P,Bouler JM,Muller R,etc.Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats.[J].2006,76(1).